Entry 0022Rev 1.0Vendor blend

KLOW

Blend of 4 research peptides · no single formula

Reviewed

2 Nov 2026

Scientific editor

[Name, PhD]

References

2 sources

KLOW is a vendor name for a mixture of four research peptides: KPV, GHK-Cu, BPC-157 and TB-500. It is GLOW with KPV, a three-residue fragment of alpha-MSH studied in inflammation models, added.

There is no published study of the four together. The science is in the four component entries.

Components

4

Combined mass

≈ 3053 g/mol total

Studies of the blend

None

WADA

Contains prohibited

01

What is in it

A blend is a mixture of separate peptides in one vial. The name is a vendor label, not a chemical name, and the ratio varies between suppliers. The table lists each component and links to its own entry, where the identity data and references live.

ComponentResiduesAvg massEntryWhat the studies measuredWADA
KPV3342.4 g/mol0006Inflammation models in cells and miceS0 by default
GHK-Cu3401.9 g/mol0003Skin and wound models in cells and animals; small human skin studiesNot named
BPC-157151419.5 g/mol0001Gut, tendon, muscle and vessel models in rats; a few small human reportsS0, prohibited
TB-5007889.0 g/mol0002Mostly studies of the parent protein thymosin beta-4; detection work on the fragmentS2.3, prohibited

KLOW is GLOW with KPV added. Combined mass is the sum of the four components.

02

What the studies measured

There is no published study of KLOW as a mixture. Everything known comes from studies of the components on their own, almost all in animals or cells. The rows below summarise those entries; the evidence for each is in its own entry.

ComponentModelMain lines of researchHuman data
KPVCells, miceInflammation in gut and skin modelsNone
GHK-CuCells, animals, peopleWound closure, collagen, skin appearanceSmall cosmetic studies
BPC-157Rats, cell culturesGut, tendon, muscle and vessel repairA few small uncontrolled reports
TB-500Mostly the parent protein, thymosin beta-4Wound, heart and eye repair for the protein; detection for the fragmentNone for the fragment
03

Regulatory and sport status

As of this revision. General information, not legal advice.

WhereStatus
UK, EU, USNo component is a licensed medicine. None is a controlled drug in the UK. May not be supplied or promoted for human use.
SportBPC-157 (class S0) and TB-500 (class S2.3) are prohibited at all times, so a blend containing them is prohibited. KPV is unapproved and falls under S0 by default; GHK-Cu is not named.2
04

Open questions

  1. Whether the components interact at all. No study has tested them together, so any claim about the mixture rests on separate studies.
  2. How a certificate should read for a blend: purity by HPLC gives one peak per peptide, and identity by mass spectrometry must confirm each one. Ask any supplier for all of them.
  3. The ratio. Different suppliers use different amounts of each peptide under the same name.
05

Common questions

What is in KLOW?

KPV, GHK-Cu, BPC-157 and TB-500 in one vial. It is GLOW plus KPV.

What does the K add?

KPV, the last three residues of alpha-MSH, studied in inflammation models in cells and mice. It has no human data.

Has KLOW been studied?

No. There is no published study of the mixture.

Is KLOW banned in sport?

Yes, in effect. BPC-157 and TB-500 are prohibited at all times, and KPV is unapproved.

—

See also

06

References

  1. Peptidarium Library. The component entries linked above, each with its own reference list.
  2. World Anti-Doping Agency. The 2026 Prohibited List (in force 1 January 2026). wada-ama.org Classes S0 and S2.3.

Peptidarium Library. KLOW (entry 0022), revision 1.0, 2 November 2026. peptidarium.com/library/klow

07

Revision history

RevDateChangeBy
1.02 Nov 2026Entry created.[Scientific editor]

Spotted an error or a missing paper? Send a correction. Every change is logged here.